The purpose of this study is to compare the effect of a blood thinning drug called Apixaban
versus no administration of a blood thinning drug, in preventing blood clots in children
with leukemia or lymphoma. Patients must be receiving chemotherapy; including Pegylated
L-Asparaginase and have a central line (a catheter inserted for administration of
medications and blood sampling).